Retraction

FoxM1-mediated RFC5 expression promotes temozolomide resistance

Paper Information

Record ID:

54064

Author(s):

Wan Xin Peng
Xiu Han
Chun Li Zhang
Lu Ge
Feng Yi Du
Jie Jin
Ai Hua Gong

Journal:

Cell Biology and Toxicology ( Springer )

Publication Date:

February 09, 2017

Retraction Date:

June 08, 2024 (1.4 year years ago)

Subjects:

Broad Categories:
Genetics Biochemistry Toxicology

Specific Fields:
Biochemistry Genetics Toxicology

Institutions:

School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, 212013, China
Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China

Country:

🇨🇳 China

Article Type:

Research Article

Publisher:

Springer

Open Access:

Yes

DOI:

10.1007/s10565-017-9381-1

PubMed ID:

28185110

Retraction PubMed ID:

38850404

Retraction Details

Retraction Reasons:

Nature of Retraction:

Retraction

Retraction Notice:

10.1007/s10565-024-09887-0

Additional Notes:

See also: https://pubpeer.com/publications/43D2E1BB3CF9FBA62CFA22A1F2A132

Citations (38)

38

Total Citations

3

Post-Retraction
(7.9%)

35

Pre-Retraction

0

Same Day

Post-Retraction Citation Analysis

1 Within 30 days

3 Within 1 year

0 After 2+ years

297 Days since retraction (latest)

Identification of clinical, prognostic and immunological impact of replication factor C subunit 5 (RFC5) expression in head and neck squamous cell carcinoma

D. V. Siva Sankar, Anitha Pandi, Palati Sinduja et al. (5 authors)

Journal of Oral and Maxillofacial Surgery Medicine and Pathology

Published: Apr 2025

297 days after retraction

Therapeutic Landscape of FOXM1 in Triple-Negative Breast Cancer and Aggressive Solid Cancers

Sayra Dilmaç, Zühal Hamurcu, Bülent Özpolat

Cancers Open Access

Published: Nov 2024
3 citations

159 days after retraction

A novel L-shaped ortho-quinone analog suppresses glioblastoma progression by targeting acceleration of AR degradation and regulating PI3K/AKT pathway

Tao Zhang, Weidong Pan, Xin Tan et al. (10 authors)

Biochemical Pharmacology

Published: Jun 2024
2 citations

19 days after retraction

Identification of expression profiles and prognostic value of RFCs in colorectal cancer

Md Misbah, Manoj Kumar, Abul Kalam Najmi et al. (4 authors)

Scientific Reports Open Access

Published: Mar 2024
4 citations

81 days before retraction

The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer Treatment

Nawal Merjaneh, Mona Hajjar, Ying‐Wei Lan et al. (5 authors)

Cancers Open Access

Published: Feb 2024
11 citations

117 days before retraction

Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics

Peyman Tabnak, Aysa Hasanzade Bashkandi, Mohammad Ebrahimnezhad et al. (4 authors)

Cancer Cell International Open Access

Published: Oct 2023
20 citations

241 days before retraction

Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation

Jing Song, Yongyao Tang, Fangzhou Song

International Journal of Oncology Open Access

Published: Aug 2023
4 citations

303 days before retraction

Construction of a prognostic signature of RFC5 immune-related genes in patients with cervical cancer

Huaqiu Chen, Huanyu Xie, Yuanyuan Zhang et al. (4 authors)

Cancer Biomarkers

Published: Jun 2023
2 citations

368 days before retraction

RFC5, regulated by circ_0038985/miR‐3614‐5p, functions as an oncogene in the progression of colorectal cancer

Huihui Yao, Xin Zhou, Aina Zhou et al. (19 authors)

Molecular Carcinogenesis

Published: Mar 2023
6 citations

437 days before retraction

A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer

Ronghua Huang, Ying‐Kai Hong, Heng Du et al. (6 authors)

Journal of Translational Medicine Open Access

Published: Jan 2023
24 citations

513 days before retraction

Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions

Wen Xu, Li Liu, Zhongqi Cui et al. (10 authors)

Open Medicine Open Access

Published: Jan 2023

524 days before retraction

Integrative analysis of expression, prognostic significance and immune infiltration of RFC family genes in human sarcoma

Gen Sheng Wu, Jian Zhou, Xi Zhu et al. (11 authors)

Aging Open Access

Published: Apr 2022
10 citations

771 days before retraction

RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas

Xu Zhao, Yuzhu Wang, Jing Li et al. (9 authors)

Scientific Reports Open Access

Published: Feb 2022
12 citations

835 days before retraction

The bacterial thiopeptide thiostrepton. An update of its mode of action, pharmacological properties and applications

Christian Bailly

European Journal of Pharmacology

Published: Dec 2021
34 citations

918 days before retraction

USP21 regulates Hippo signaling to promote radioresistance by deubiquitinating FOXM1 in cervical cancer

Zhengliang Li, Xiaojing Liu, Haizhou Yu et al. (6 authors)

Human Cell

Published: Nov 2021
35 citations

926 days before retraction

NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma

Xiangsheng Su, Yihang Yang, Qing Yang et al. (10 authors)

BMC Cancer Open Access

Published: Nov 2021
24 citations

946 days before retraction

Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values

Tengyong Wang, Xiaoxuan Chen, Fangqi Jing et al. (7 authors)

Pathology - Research and Practice

Published: Oct 2021
5 citations

968 days before retraction

Identification of biomarkers for acute leukemia via machine learning-based stemness index

Yitong Zhang, Dongzhe Liu, Fenglan Li et al. (8 authors)

Gene

Published: Aug 2021
17 citations

1027 days before retraction

AEG-1 Knockdown Sensitizes Glioma Cells to Radiation Through Impairing Homologous Recombination Via Targeting RFC5

Xu Zhao, Yuchen Sun, Xuanzi Sun et al. (8 authors)

DNA and Cell Biology

Published: May 2021
7 citations

1108 days before retraction

Forkhead box O1 targeting replication factor C subunit 2 expression promotes glioma temozolomide resistance and survival

Xingsheng Qiu, Guifeng Tan, Hao Wen et al. (5 authors)

Annals of Translational Medicine Open Access

Published: Apr 2021
10 citations

1164 days before retraction

The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor

Yuichi Shibui, Kenichi Kohashi, Akihiko Tamaki et al. (8 authors)

Journal of Cancer Research and Clinical Oncology Open Access

Published: Nov 2020
11 citations

1295 days before retraction

FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A

Hongbo Yu, Zheng Xu, Maomao Guo et al. (11 authors)

Cancer Cell International Open Access

Published: Nov 2020
33 citations

1306 days before retraction

Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas

Wenjing Zeng, Quan Cheng, Zhipeng Wen et al. (8 authors)

Journal of Cellular and Molecular Medicine Open Access

Published: Jul 2020
25 citations

1424 days before retraction

Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors

Carsten Kroeger, Reinhild Roesler, Sebastian Wiese et al. (5 authors)

International Journal of Molecular Sciences Open Access

Published: May 2020
9 citations

1474 days before retraction

FOXM1: a potential therapeutic target in human solid cancers

Soheila Borhani, Andrei L. Gartel

Expert Opinion on Therapeutic Targets

Published: Feb 2020
78 citations

1572 days before retraction

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis

Jun‐Hai Tang, Lin Yang, Juxiang Chen et al. (12 authors)

Cancer Communications Open Access

Published: Dec 2019
76 citations

1651 days before retraction

Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients

Qi Yang, Rui Wang, Bo Wei et al. (8 authors)

DNA and Cell Biology

Published: Jun 2019
10 citations

1823 days before retraction

A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes

Irene Bertolini, Andrea Terrasi, Cristina Martelli et al. (14 authors)

EBioMedicine Open Access

Published: Feb 2019
38 citations

1949 days before retraction

The Dominant Role of Forkhead Box Proteins in Cancer

Duc‐Hiep Bach, Nguyen Phuoc Long, Thi-Thu-Trang Luu et al. (6 authors)

International Journal of Molecular Sciences Open Access

Published: Oct 2018
91 citations

2056 days before retraction

Identification of RFC5 as a novel potential prognostic biomarker in lung cancer through bioinformatics analysis

Meng Wang, Tian Xie, Yingjie Wu et al. (8 authors)

Oncology Letters Open Access

Published: Jul 2018
17 citations

2144 days before retraction

Identification of a DNA Repair-Related Multigene Signature as a Novel Prognostic Predictor of Glioblastoma

Shuai Jin, Zenghui Qian, Tingyu Liang et al. (9 authors)

World Neurosurgery

Published: May 2018
8 citations

2205 days before retraction

FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma

Chunli Zhang, Xiu Han, Xu Xiao et al. (16 authors)

Cell Death and Disease Open Access

Published: Apr 2018
46 citations

2238 days before retraction

Multifaceted regulation and functions of replication factor C family in human cancers.

Yanling Li, Sijie Gan, Lin Ren et al. (11 authors)

PubMed

Published: Jan 2018
65 citations

2350 days before retraction

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance

Shang J. Yao, Lavender Yuen-Nam Fan, Eric W.‐F. Lam

Seminars in Cancer Biology Open Access

Published: Nov 2017
201 citations

2387 days before retraction

The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma

Qing Ma, Yanmei Liu, Liang Shang et al. (5 authors)

Oncology Reports Open Access

Published: Oct 2017
56 citations

2431 days before retraction

FoxM1: Repurposing an oncogene as a biomarker

Deeptashree Nandi, Pradeep Singh Cheema, Neha Jaiswal et al. (4 authors)

Seminars in Cancer Biology

Published: Aug 2017
142 citations

2474 days before retraction

The Role of DNA Repair in Maintaining Mitochondrial DNA Stability

Linlin Zhang, Aurelio Reyes, Xiangdong Wang

Advances in experimental medicine and biology Open Access

Published: Jan 2017
6 citations

2715 days before retraction

How Far Can Mitochondrial DNA Drive the Disease?

Hongzhi Sun, Weibin Shi, Xiangdong Wang

Advances in experimental medicine and biology

Published: Jan 2017
7 citations

2715 days before retraction

Quick Stats

Total Citations: 38

Years Since Retraction: 1.4 year

Open Access: Yes

Last Checked: Jul 24, 2025

Actions

More from this journal Similar subjects View Original Paper View Retraction Notice